Market Cap ₹683 Cr.
Stock P/E 0.0
P/B 5.1
Current Price ₹324.4
Book Value ₹ 64.2
Face Value 10
52W High ₹364
Dividend Yield 0%
52W Low ₹ 224
Accent Microcell Ltd. is an India based manufacturer of microcrystalline cellulose (MCC), a refined wood pulp used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production and vitamin supplements. The company was founded in 2012 by Mr. Pratik Patel, who envisioned to create a world-class facility for producing high-quality MCC in India. Since then, They has expanded company's product portfolio to include magnesium stearate, cross carmellose sodium, and cellulose powder. The company has also achieved several milestones, such as installing a glass line reactor, using alpha cellulose dissolving rayon grade wood pulp, ranking number one in MCC production in India, having an installed capacity of around 12000 MT annually, and obtaining various quality certificates and approvals.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|
| Net Sales | 133 | 166 | 204 | |
| Other Income | 2 | 2 | 3 | |
| Total Income | 135 | 168 | 207 | |
| Total Expenditure | 122 | 153 | 185 | |
| Operating Profit | 13 | 15 | 22 | |
| Interest | 3 | 3 | 3 | |
| Depreciation | 4 | 4 | 4 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | |
| Profit Before Tax | 6 | 8 | 15 | |
| Provision for Tax | 1 | 2 | 2 | |
| Profit After Tax | 5 | 6 | 13 | |
| Adjustments | 0 | 0 | 0 | |
| Profit After Adjustments | 5 | 6 | 13 | |
| Adjusted Earnings Per Share | 3.7 | 1.5 | 10.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 23% | 0% | 0% | 0% |
| Operating Profit CAGR | 47% | 0% | 0% | 0% |
| PAT CAGR | 117% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 34% | 24% | 24% | 24% |
| ROCE Average | 29% | 21% | 21% | 21% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Shareholder's Funds | 27 | 32 | 44 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 18 | 7 | 5 |
| Other Non-Current Liabilities | 1 | 2 | 2 |
| Total Current Liabilities | 35 | 54 | 63 |
| Total Liabilities | 81 | 95 | 114 |
| Fixed Assets | 30 | 30 | 30 |
| Other Non-Current Assets | 1 | 1 | 1 |
| Total Current Assets | 50 | 64 | 82 |
| Total Assets | 81 | 95 | 114 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 4 | 0 | 1 |
| Cash Flow from Operating Activities | 5 | 15 | 8 |
| Cash Flow from Investing Activities | -6 | -4 | -4 |
| Cash Flow from Financing Activities | -2 | -10 | -4 |
| Net Cash Inflow / Outflow | -3 | 1 | -1 |
| Closing Cash & Cash Equivalent | 0 | 1 | 0 |
| # | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Earnings Per Share (Rs) | 3.72 | 1.52 | 10.05 |
| CEPS(Rs) | 6.48 | 2.59 | 13.24 |
| DPS(Rs) | 1 | 0.8 | 0.8 |
| Book NAV/Share(Rs) | 20.64 | 8.29 | 34.15 |
| Core EBITDA Margin(%) | 8.06 | 7.83 | 9.49 |
| EBIT Margin(%) | 7.08 | 6.43 | 8.83 |
| Pre Tax Margin(%) | 4.53 | 4.58 | 7.59 |
| PAT Margin (%) | 3.62 | 3.56 | 6.37 |
| Cash Profit Margin (%) | 6.3 | 6.06 | 8.4 |
| ROA(%) | 5.95 | 6.72 | 12.47 |
| ROE(%) | 18.04 | 20.07 | 34.11 |
| ROCE(%) | 16.38 | 18.78 | 29.27 |
| Receivable days | 34.72 | 32.66 | 36.61 |
| Inventory Days | 86.87 | 78.34 | 83.33 |
| Payable days | 74.35 | 78.01 | 81.95 |
| PER(x) | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.25 | 0.21 | 0.16 |
| EV/Core EBITDA(x) | 2.59 | 2.31 | 1.52 |
| Net Sales Growth(%) | 0 | 25 | 23.22 |
| EBIT Growth(%) | 0 | 13.58 | 69.17 |
| PAT Growth(%) | 0 | 22.7 | 120.77 |
| EPS Growth(%) | 0 | -59.1 | 560.26 |
| Debt/Equity(x) | 1.15 | 0.75 | 0.52 |
| Current Ratio(x) | 1.43 | 1.19 | 1.31 |
| Quick Ratio(x) | 0.52 | 0.45 | 0.46 |
| Interest Cover(x) | 2.78 | 3.48 | 7.11 |
| Total Debt/Mcap(x) | 0 | 0 | 0 |
| # | Mar 2024 |
|---|---|
| Promoter | 55.09 |
| FII | 0.03 |
| DII | 1.63 |
| Public | 43.25 |
| Others | 0 |
| Total | 100 |
| # | Mar 2024 |
|---|---|
| Promoter | 1.16 |
| FII | 0 |
| DII | 0.03 |
| Public | 0.91 |
| Others | 0 |
| Total | 2.1 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
